BrainStorm Cell Therapeutics
BCLI
#10401
Rank
NZ$11.44 M
Marketcap
NZ$1.04
Share price
0.00%
Change (1 day)
-61.52%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Net assets

Net assets on the balance sheet as of June 2025 : -NZ$10.48 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company has -NZ$10.48 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BrainStorm Cell Therapeutics - Net assets on balance sheet (from 2002 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-NZ$13.77 Million79.21%
2023-12-31$-NZ$7.69 Million61.76%
2022-12-31$-NZ$4.75 Million-116.77%
2021-12-31$NZ$28.31 M-42.39%
2020-12-31$NZ$49.15 M-370.82%
2019-12-31$-NZ$18.15 Million-342.7%
2018-12-31$NZ$7.47 M-9.68%
2017-12-31$NZ$8.27 M-42.08%
2016-12-31$NZ$14.29 M-30.75%
2015-12-31$NZ$20.64 M142.3%
2014-12-31$NZ$8.51 M155.6%
2013-12-31$NZ$3.33 M-31.14%
2012-12-31$NZ$4.84 M153.89%
2011-12-31$NZ$1.9 M-420.46%
2010-12-31$-NZ$0.6 Million-75.21%
2009-12-31$-NZ$2.4 Million-32.92%
2008-12-31$-NZ$3.58 Million12.86%
2007-12-31$-NZ$3.17 Million22.97%
2006-12-31$-NZ$2.58 Million
2006-03-31$-NZ$13.08 Million-1419.93%
2005-03-31$NZ$0.99 M-2202.63%
2004-03-31$-NZ$0.05 Million-228.09%
2003-03-31$NZ$0.03 M-68.94%
2002-03-31$NZ$0.11 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
NZ$37.10 B-354,334.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-NZ$0.91 Billion 8,503.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
NZ$4.41 B-42,206.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$31.48 B-300,702.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
-NZ$0.49 Billion 4,537.08%๐Ÿ‡บ๐Ÿ‡ธ USA